Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activin receptor-like kinases: structure, function and clinical implications.

Heather Graham1, Chun Peng

  • 1Department of Biology, York University, Toronto, Canada.

Endocrine, Metabolic & Immune Disorders Drug Targets
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-power coherently combined femtosecond laser based on InnoSlab amplifiers.

Optics letters·2026
Same author

Physical Activity Trajectories and Bone Mineral Density in Adults: Indirect Associations of Skeletal Muscle Mass and Body Fat.

Calcified tissue international·2025
Same author

Aryl hydrocarbon receptor-induced activation of AIM2 inflammasome is mediated by MOMP and MPT: A vital therapeutic pathway for inflammation.

Cell reports·2025
Same author

Communicating Discoveries in the Search for Life in the Universe Workshop Report.

Astrobiology·2025
Same author

8:2 fluorotelomer alcohol exacerbates doxorubicin-induced cardiotoxicity and chemoresistance via aryl hydrocarbon receptor.

Ecotoxicology and environmental safety·2025
Same author

Feasibility of outpatient middle meningeal artery embolization for chronic subdural hematoma.

Surgical neurology international·2025
Same journal

Denosumab is Associated with Improved Liver Function and Reduced Fibrosis Scores in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease and Osteoporosis: A Retrospective Observational Study.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Expression of IL-35 in the Prophase of Liver Failure and its Immune Regulatory Interaction with Glucocorticoids.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Celastrol Attenuates Fgf23 Expression in Osteoblasts by Inhibiting STAT3 Activation.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Mendelian Randomization Analysis of the Inflammatory Factor CXCL5 and Type 2 Diabetes Mellitus.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas.

Endocrine, metabolic & immune disorders drug targets·2026
See all related articles

Activin receptor-like kinases (ALKs) are crucial type I receptors in transforming growth factor-beta (TGF-beta) superfamily signaling. These receptors regulate vital cellular processes and are implicated in various diseases, making them potential drug targets.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • The transforming growth factor-beta (TGF-beta) superfamily governs numerous cellular functions throughout vertebrate development.
  • TGF-beta signaling relies on heteromeric receptor complexes, with type I receptors (activin receptor-like kinases, ALKs) initiating the intracellular cascade.

Purpose of the Study:

  • To elucidate the structural and functional significance of activin receptor-like kinases (ALKs) in TGF-beta superfamily signaling.
  • To highlight the role of ALKs in diverse cellular processes and their implication in human diseases.

Main Methods:

  • Review and synthesis of existing literature on TGF-beta superfamily signaling pathways.
  • Analysis of the structural components of ALKs, including extracellular, transmembrane, GS, and kinase domains.

Related Experiment Videos

  • Examination of the downstream signaling mediated by ALKs through Smad proteins.

    • Main Results:

    • Seven ALKs have been identified in mammals, each playing a role in TGF-beta superfamily signal transduction.
    • ALKs are essential for regulating cellular proliferation, differentiation, apoptosis, adhesion, and migration.
    • Dysregulation of ALK signaling is linked to tumorigenesis, hemorrhagic telangiectasia (HHT), immune and renal diseases, and skeletal disorders.

    Conclusions:

    • Activin receptor-like kinases are central mediators of TGF-beta superfamily signaling, impacting fundamental biological processes.
    • The involvement of ALKs in various pathologies underscores their potential as therapeutic targets for a range of diseases.